complete primary vaccine series in COVID-19 prophylaxis (excluding children) - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias deathsdetailed results UKHSA report week 12 (24 March 2022), 2022 0.45 [0.19; 1.05]
0.45 [0.19 ; 1.05 ] UKHSA report week 12 (24 March 2022), 2022 1 0% NA not evaluable deaths (time to event analysis only)detailed results UKHSA report week 12 (24 March 2022), 2022 0.45 [0.19; 1.05]
0.45 [0.19 ; 1.05 ] UKHSA report week 12 (24 March 2022), 2022 1 0% NA not evaluable clinical deteriorationdetailed results Lauring, 2022 0.44 [0.37; 0.52]
0.44 [0.37 ; 0.52 ] Lauring, 2022 1 0% 11,690 NA not evaluable confirmed COVID (any severity)detailed results England (Andrews), 2021 0.51 [0.35; 0.76]
South Africa (Discovery Health, Collie), 2021 0.50 [0.38; 0.65]
Southern California (Tseng) - omicron, 2022 0.70 [0.51; 0.95]
Tenforde, 2022 0.18 [0.14; 0.23]
Thompson -VISIOn Network (omicron), 2022 0.48 [0.42; 0.54]
0.43 [0.28 ; 0.66 ] England (Andrews), 2021, South Africa (Discovery Health, Collie), 2021, Southern California (Tseng) - omicron, 2022, Tenforde, 2022, Thompson -VISIOn Network (omicron), 2022 5 93% 138,105 NA not evaluable hospitalizationdetailed results Lauring, 2022 0.15 [0.12; 0.18]
South Africa (Discovery Health, Collie), 2021 0.30 [0.24; 0.38]
Thompson -VISIOn Network (omicron), 2022 0.19 [0.10; 0.36]
0.21 [0.12 ; 0.35 ] Lauring, 2022, South Africa (Discovery Health, Collie), 2021, Thompson -VISIOn Network (omicron), 2022 3 90% 11,690 NA not evaluable symptomatic Covid-19detailed results England (Andrews), 2021 0.51 [0.35; 0.76]
Kirsebom (UKHSA), 2022 0.76 [0.72; 0.80]
South Africa (Discovery Health, Collie), 2021 0.50 [0.38; 0.65]
Thompson -VISIOn Network (omicron), 2022 0.48 [0.42; 0.54]
0.56 [0.41 ; 0.77 ] England (Andrews), 2021, Kirsebom (UKHSA), 2022, South Africa (Discovery Health, Collie), 2021, Thompson -VISIOn Network (omicron), 2022 4 94% 131,448 NA not evaluable 0.0 2.0 1.0 relative treatment effect www.metaEvidence.org 2024-06-17 18:54 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
